Acrivon Therapeutics, Inc. (ACRV)
2.10
+0.04
(+1.94%)
USD |
NASDAQ |
Aug 31, 16:00
2.05
-0.05
(-2.38%)
After-Hours: 19:02
Acrivon Therapeutics Market Cap : 89.98M for Aug. 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 88.27M |
| August 27, 2026 | 92.12M |
| August 26, 2026 | 89.12M |
| August 25, 2026 | 93.41M |
| August 24, 2026 | 94.26M |
| August 21, 2026 | 94.69M |
| August 20, 2026 | 94.26M |
| August 19, 2026 | 102.40M |
| August 18, 2026 | 87.84M |
| August 17, 2026 | 87.84M |
| August 14, 2026 | 83.55M |
| August 13, 2026 | 79.27M |
| August 12, 2026 | 73.70M |
| August 11, 2026 | 74.13M |
| August 10, 2026 | 74.55M |
| August 07, 2026 | 67.03M |
| August 06, 2026 | 65.48M |
| August 05, 2026 | 63.54M |
| August 04, 2026 | 60.44M |
| August 03, 2026 | 60.44M |
| July 31, 2026 | 58.12M |
| July 30, 2026 | 58.89M |
| July 29, 2026 | 55.41M |
| July 28, 2026 | 59.67M |
| July 27, 2026 | 60.44M |
| Date | Value |
|---|---|
| July 24, 2026 | 61.99M |
| July 23, 2026 | 64.70M |
| July 22, 2026 | 65.09M |
| July 21, 2026 | 67.80M |
| July 20, 2026 | 67.42M |
| July 17, 2026 | 67.80M |
| July 16, 2026 | 67.80M |
| July 15, 2026 | 74.39M |
| July 14, 2026 | 82.53M |
| July 13, 2026 | 76.72M |
| July 10, 2026 | 75.94M |
| July 09, 2026 | 79.43M |
| July 08, 2026 | 79.04M |
| July 07, 2026 | 72.07M |
| July 06, 2026 | 68.97M |
| July 02, 2026 | 66.64M |
| July 01, 2026 | 67.03M |
| June 30, 2026 | 68.97M |
| June 29, 2026 | 68.97M |
| June 26, 2026 | 65.09M |
| June 25, 2026 | 61.22M |
| June 24, 2026 | 62.77M |
| June 23, 2026 | 63.15M |
| June 22, 2026 | 61.22M |
| June 18, 2026 | 60.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.976B |
| Alnylam Pharmaceuticals, Inc. | 32.19B |
| Anika Therapeutics, Inc. | 276.23M |
| Savara, Inc. | 1.107B |
| Vericel Corp. | 2.041B |
Market Cap Related Metrics
| Price to Book Value | 1.038 |
| Price | 2.10 |
| Earnings Yield | -89.76% |